Cargando…

ANTIGENIC VARIANTS OF INFLUENZA A VIRUS (PR8 STRAIN) : V. VIRULENCE, ANTIGENIC POTENCY, AND CROSS-PROTECTION TESTS IN MICE OF THE ORIGINAL AND SECOND SERIES

Two series of variants of influenza PR8-S virus have been described. While all retain the same degree of pathogenicity for mice and fertile eggs, there was a progressive loss in the ability of the variants to provoke antibody following vaccination or infection of mice and ferrets. The immunogenicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Loosli, Clayton G., Hamre, Dorothy, Gerber, Paul
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1958
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2136855/
https://www.ncbi.nlm.nih.gov/pubmed/13539310
_version_ 1782143217120051200
author Loosli, Clayton G.
Hamre, Dorothy
Gerber, Paul
author_facet Loosli, Clayton G.
Hamre, Dorothy
Gerber, Paul
author_sort Loosli, Clayton G.
collection PubMed
description Two series of variants of influenza PR8-S virus have been described. While all retain the same degree of pathogenicity for mice and fertile eggs, there was a progressive loss in the ability of the variants to provoke antibody following vaccination or infection of mice and ferrets. The immunogenicity of the variants was, therefore, less than that of the original strain. Although little or no serological relationship could be demonstrated between some of the variants and the PR8-S virus a considerable degree of cross-immunity could be demonstrated in the cross-protection tests with these viruses if observations were based solely on death or survival of the mice. By employing the occurrence of lesions in the lung and the titer of virus in the lung 48 hours after challenge, the amount of cross-protection in mice could be related to the amount of serological cross-reaction. In general mice vaccinated with PR8-S virus were less resistant to infection with the variant viruses than mice vaccinated with variants and challenged with the PR8-S parent virus. The role of the immune environment of the host in the production of the variant influenza viruses with their serological differences, decreasing antigenicity, and persisting pathogenicity as well as the epidemiological implications of these findings with respect to epidemic influenza in man are discussed.
format Text
id pubmed-2136855
institution National Center for Biotechnology Information
language English
publishDate 1958
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21368552008-04-17 ANTIGENIC VARIANTS OF INFLUENZA A VIRUS (PR8 STRAIN) : V. VIRULENCE, ANTIGENIC POTENCY, AND CROSS-PROTECTION TESTS IN MICE OF THE ORIGINAL AND SECOND SERIES Loosli, Clayton G. Hamre, Dorothy Gerber, Paul J Exp Med Article Two series of variants of influenza PR8-S virus have been described. While all retain the same degree of pathogenicity for mice and fertile eggs, there was a progressive loss in the ability of the variants to provoke antibody following vaccination or infection of mice and ferrets. The immunogenicity of the variants was, therefore, less than that of the original strain. Although little or no serological relationship could be demonstrated between some of the variants and the PR8-S virus a considerable degree of cross-immunity could be demonstrated in the cross-protection tests with these viruses if observations were based solely on death or survival of the mice. By employing the occurrence of lesions in the lung and the titer of virus in the lung 48 hours after challenge, the amount of cross-protection in mice could be related to the amount of serological cross-reaction. In general mice vaccinated with PR8-S virus were less resistant to infection with the variant viruses than mice vaccinated with variants and challenged with the PR8-S parent virus. The role of the immune environment of the host in the production of the variant influenza viruses with their serological differences, decreasing antigenicity, and persisting pathogenicity as well as the epidemiological implications of these findings with respect to epidemic influenza in man are discussed. The Rockefeller University Press 1958-06-01 /pmc/articles/PMC2136855/ /pubmed/13539310 Text en Copyright © Copyright, 1958, by The Rockefeller Institute for Medical Research New York This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Loosli, Clayton G.
Hamre, Dorothy
Gerber, Paul
ANTIGENIC VARIANTS OF INFLUENZA A VIRUS (PR8 STRAIN) : V. VIRULENCE, ANTIGENIC POTENCY, AND CROSS-PROTECTION TESTS IN MICE OF THE ORIGINAL AND SECOND SERIES
title ANTIGENIC VARIANTS OF INFLUENZA A VIRUS (PR8 STRAIN) : V. VIRULENCE, ANTIGENIC POTENCY, AND CROSS-PROTECTION TESTS IN MICE OF THE ORIGINAL AND SECOND SERIES
title_full ANTIGENIC VARIANTS OF INFLUENZA A VIRUS (PR8 STRAIN) : V. VIRULENCE, ANTIGENIC POTENCY, AND CROSS-PROTECTION TESTS IN MICE OF THE ORIGINAL AND SECOND SERIES
title_fullStr ANTIGENIC VARIANTS OF INFLUENZA A VIRUS (PR8 STRAIN) : V. VIRULENCE, ANTIGENIC POTENCY, AND CROSS-PROTECTION TESTS IN MICE OF THE ORIGINAL AND SECOND SERIES
title_full_unstemmed ANTIGENIC VARIANTS OF INFLUENZA A VIRUS (PR8 STRAIN) : V. VIRULENCE, ANTIGENIC POTENCY, AND CROSS-PROTECTION TESTS IN MICE OF THE ORIGINAL AND SECOND SERIES
title_short ANTIGENIC VARIANTS OF INFLUENZA A VIRUS (PR8 STRAIN) : V. VIRULENCE, ANTIGENIC POTENCY, AND CROSS-PROTECTION TESTS IN MICE OF THE ORIGINAL AND SECOND SERIES
title_sort antigenic variants of influenza a virus (pr8 strain) : v. virulence, antigenic potency, and cross-protection tests in mice of the original and second series
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2136855/
https://www.ncbi.nlm.nih.gov/pubmed/13539310
work_keys_str_mv AT loosliclaytong antigenicvariantsofinfluenzaaviruspr8strainvvirulenceantigenicpotencyandcrossprotectiontestsinmiceoftheoriginalandsecondseries
AT hamredorothy antigenicvariantsofinfluenzaaviruspr8strainvvirulenceantigenicpotencyandcrossprotectiontestsinmiceoftheoriginalandsecondseries
AT gerberpaul antigenicvariantsofinfluenzaaviruspr8strainvvirulenceantigenicpotencyandcrossprotectiontestsinmiceoftheoriginalandsecondseries